Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

FED × Anxiety Disorders × Midazolam × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Respiratory Aspiration 1 Respiration Disorders 1 Rare Diseases 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Anxiety Disorders 1

Interventions

Midazolam 1 Ketamine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03043430 2023-04-25

Intranasal Ketamine for Anxiolysis in Pediatric Emergency Department Patients

Brooke Army Medical Center

Phase 4 Terminated

LymphoidOther hematologic neoplasm

Anxiety Disorders, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡